The Induction of Class I and II Major Histocompatibility Complex by Allogeneic Stimulation Is Dependent on the Transcription Factor Interferon Regulatory Factor 1 (IRF-1): Observations in IRF-1 Knockout Mice

Transplantation

Volumn 62, Issue 12, 1996, Pages 1895-1901

  Hobart, Michael ^a   Ramassar, Vido ^a   Goes, Nelson ^a   Urmson, Joan ^a   Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOREGULATION; IMMUNOSTIMULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GENES, MHC CLASS II; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; PHOSPHOPROTEINS; RNA, MESSENGER;

EID: 0030457133     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199612270-00037     Document Type: Article

References (58)

1. Halloran PF, Jephthah-Ochola J, Urmson J, Farkas S. Systemic immunologic stimuli increase class I and II antigen expression in mouse kidney. J Immunol 1985; 135: 1053.
2. Halloran PF, Autenried P, Ramassar V, Urmson J, Cockfield S. Local T cell responses induce widespread MHC expression: evidence that IFN-γ induces its own expression in remote sites. J Immunol 1992; 148: 3837.
3. Jephthah-Ochola J, Urmson J, Farkas S, Halloran PF. Regulation of MHC in vivo. Bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cell independent, cyclosporine sensitive mechanism. J Immunol 1988; 141: 792.
4. Halloran PF, Urmson J, Farkas S, et al. Effects of cyclosporine on systemic MHC expression: evidence that non T cells produce gamma interferon in vivo and are inhibitable by cyclosporine A. Transplantation 1988; 46: 68S.
5. Goes N, Sims T, Urmson J, Vincent D, Ramassar V, Halloran PF. Disturbed MHC regulation in the interferon-γ knockout mouse. J Immunol 1995; 155: 4559.
6. Halloran PF, Urmson J, Farkas S, van der Meide P, Autenried P. Regulation of MHC expression in vivo: IFN-α/β inducers and recombinant IFN-α modulate MHC antigen expression in mouse tissues. J Immunol 1989; 142: 4241.
7. Blanchard DK, Djeu JY, Klein TW, Freidman H, Stewart WE. Interferon-γ induction by lipopolysaccharide: dependence on interleukin-2 and macrophages. J Immunol 1986; 136: 963.
8. Belitsky P, Miller SM, Gupta R, Lee S, Ghose T. Induction of MHC class II expression in recipient tissues caused by allograft rejection. Transplantation 1990; 49: 472.
9. Campbell PM, Pimm J, Ramassar V, Halloran PF. Identification of a calcium inducible, cyclosporine-sensitive element in the IFN-γ promoter that is a potential NFAT binding site. Transplantation 1996; 61: 933.
10. Campbell P, Pimm J, Ramassar V, Halloran PF. Identification of a cyclosporine (CsA) sensitive element in the IFN-gamma promoter. FASEB J 1995; 9: A489.
11. Ihle JN, Witthuhn BA, Quelle FW, et al. Signaling by the cytokine receptor superfamily: JAKs and STATs. TIBS 1994; 19: 222.
12. Shuai K, Horvath CM, Tsai Huang LH, Qureshi SA, Cowburn D, Darnell JE Jr. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 1994; 76: 821.
13. Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T, Taniguchi T. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 1990; 63: 303.
14. Chang CH, Hammer J, Loh JE, Fodor WL, Flavell RA. The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1). Immunogenetics 1992; 35: 378.
15. b. EMBO J 1989; 8: 1139.
16. Fujita T, Reis LFL, Watanabe N, Kimura Y, Taniguchi T, Vilcek J. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci USA 1989; 86: 9936.
17. Nelson N, Marks MS, Driggers PH, Ozato K. Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol 1993; 13: 588.
18. Harada H, Fujita T, Miyamoto M, et al. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 1989; 58: 729.
19. Veals SA, Schindler C, Leonard D, Fu XY, Aebersold R, Darnell JE, Jr., Levy DE. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol 1992; 12: 3315.
20. Driggers PH, Ernest DL, Mak WH, et al. An interferon-γ regulated protein that binds the interferon inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1990; 87: 3743.
21. Grant CE, Vasa MZ, Deeley RG. cIRF-3, a new member of the interferon regulatory factor (IRF) family is rapidly and transiently induced by dsRNA. Nucleic Acids Res 1995; 23: 2137.
22. Eisenbeis CF, Singh H, Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 1995; 9: 1377.
23. Abouna GM, Kumar MS, Stephan R, et al. Induction therapy with antithymocyte globulin reduces the incidence of allograft rejection and improves graft survival in cadaver renal transplantation. Transplant Proc 1993; 25: 2241.
24. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 1994; 265: 106.
25. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993; 75: 135.
26. Reith W, Steimle V, Mach B. Molecular defects in the bare lymphocyte syndrome and regulation of MHC class II genes. Immunol Today 1995; 16: 539.
27. Matsuyama T, Kimura T, Kitagawa M, et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993; 75: 83.
28. Salacinski PRP, McLean C, Sykes JEC, Clements-Jones VV, Lowry PJ. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3,6-diphenyl glycoluril (Iodogen). Anal Biochem 1981; 117: 136.
29. Cockfield SM, Ramassar V, Urmson J, Halloran PF. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-γ. J Immunol 1989; 142: 1120.
30. Halloran PF, Urmson J, Ramassar V, Laskin C, Autenried P. Increased class I and class II MHC products and mRNA in kidneys of MRL-lpr/lpr mice during autoimmune nephritis and inhibition by cyclosporine. J Immunol 1988; 141: 2303.
31. Chirgwin JM, Pryzybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294.
32. Hancock WW, Kraft N, Atkins RC. The immunohistochemical demonstration of major histocompatibility antigens in the human kidney using monoclonal antibodies. Pathology 1982; 14: 409.
33. 2-microglobulin genes in vivo. J Immunol 1993; 150: 2805.
34. Nielsch U, Zimmer SG, Babiss LE. Changes in NF-κB and ISGF3 DNA binding activities are responsible for differences in MHC and β-IFN gene expression in Ad5- versus AD 12-transformed cells. EMBO J 1991; 10: 4169.
35. Burke PA, Hirschfeld S, Shirayoshi Y, et al. Developmental and tissue-specific expression of nuclear proteins that bind the regulatory element of the major histocompatibility complex class I gene. J Exp Med 1989; 169: 1309.
36. Baldwin AS Jr, Sharp PA. Two transcription factors, NF-κB and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter. Proc Natl Acad Sci USA 1988; 95: 723.
37. Dey A, Thornton AM, Lonergan M, Weissman SM, Chamberlain JW, Ozato K. Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues. Mol Cell Biol 1992; 12: 3590.
38. b promoter: enhancer-like sequences and their role in the regulation of class I gene expression. Cell 1986; 44: 261.
39. bm1 class I MHC gene. EMBO J 1990; 9: 127.
40. Israël A, Kimura A, Fournier A, Fellous M, Kourislsky P. Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature 1986; 322: 743.
41. Israël A, Le Bail O, Hatat D, et al. TNF stimulates expression of mouse MHC class I genes by inducing an NFκB-like enhancer binding activity which displaces constitutive factors. EMBO J 1989; 8: 3793.
42. Johnson DR, Pober JS. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol Cell Biol 1994; 14: 1322.
43. Drew PD, Franzoso G, Carlson LM, Biddison WE, Siebenlist U, Ozato K. Interferon regulatory factor 2 physically interacts with NF-κB in vitro and inhibits NF-κB induction of major histocompatibility class I and β 2 microglobulin gene expression in transfected human neuroblastoma cells. J Interfer Cytokine Res 1995; 15: 1037.
44. Benoist C, Mathis D. Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annu Rev Immunol 1990; 8: 681.
45. Glimcher LH, Kara CJ. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992; 10: 13.
46. Ting JPY, Baldwin AS, Jr. Regulation of MHC gene expression. Curr Opin Immunol 1993; 5: 8.
47. Gronhoj Larsen C, Thomsen MK, Gesser B, et al. The delayed-type hypersensitivity reaction is dependent on IL-8: inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J Immunol 1995; 155: 2151.
48. Ramassar V, Goes N, Hobart M, Halloran PF. Evidence for the in vivo role of class II transactivator (CIITA) in basal and IFN-γ induced class II expression in mouse tissues. Transplantation (in press).
49. Rein RS, Seemann GH, Neefjes JJ, Hochstenbach FMH, Stam NJ, Pleogh HL. Association with β2-microglobulin controls the expression of transfected human class I genes. J Immunol 1987; 138: 1178.
50. Halloran PF, Madrenas J. Regulation of MHC transcription. Transplantation 1990; 50: 725.
51. Matis LA, Glimcher LH, Paul WE, Schwartz RH. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci USA 1983; 80: 6019.
52. Lechler RI, Norcross MA, Germain RN. Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells. J Immunol 1985; 135: 2914.
53. a complex expression causes a corresponding defect in antigen presentation. J Exp Med 1982; 155: 508.
54. a complex. J Exp Med 1982; 155: 490.
55. Frels WI, Bordallo C, Golding H, Rosenberg A, Rudikoff S, Singer DS. Expression of a class I MHC transgene: regulation by a tissue-specific negative regulatory DNA sequence element. New Biologist 1990; 2: 1024.
56. Statter MB, Fahrner KJ, Barksdale EM Jr, Parks DE, Flavell RA, Donahoe PK. Correlation of fetal kidney and testis congenic graft survival with reduced major histocompatibility complex burden. Transplantation 1989; 47: 651.
57. Meraz MA, White JM, Sheehan KCF, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84: 431.
58. Goes N, Urmson J, Hobart M, Halloran PF. The unique role of interferon-γ in the regulation of MHC expression on arterial endothelium. Transplantation (in press).